Bolli Thoroddsen

Bolli Thoroddsen, CEO

Major projects

  • Pharma: Establishment of a JV between Actavis Group and Aska Pharma, a Takeda Group company
  • Pharma: Acquisition of Actavis' manufacturing site in Iceland and establishment of a new pharma company, Coripharma, which Takanawa is a shareholder in
  • Skincare: Establishment of BIOEFFECT, a pioneer in the manufacturing of growth factors and recombinant proteins in plants for skincare, in Japan
  • Health food: Partnership with the dairy companies MS in Iceland and Nippon Luna in Japan for Ísey Skyr, a dairy product
  • Green Energy: Financing of a 90 MW geothermal plant for Iceland National Power Company with JBIC, NEXI, Citi Bank, Commerzbank and Bank of Yokohama


  • Since 2010 CEO, Takanawa
  • 2009 – 2010 Advisor, Actavis Group
  • 2009 – 2010 Advisor, MEDIS Pharma
  • 2009 – 2010 Advisor, Iceland Embassy in Japan
  • 2007 – 2009 Project Manager, Actavis Group


  • M.Sc. in Finance, Waseda University, Japan
  • B.Sc. in Industrial Engineering, University of Iceland

Civic Engagement

  • 2013 – 2019 Chairman of the Icelandic Chamber of Commerce in Japan
  • 2013 – 2019 Director of European Business Council in Japan
  • 2006 – 2010 Elected 2nd Deputy Council Member for Reykjavik’s City Council, Iceland